Dr. Daniel Jones and Dr. C. Michael Gibson Discuss: A Randomised Controlled Trial Assessing The Value Of Computed Tomography Cardiac Angiography (CTCA) In Improving Patient Satisfaction And Reducing Contrast Load, Procedural Duration And Complications In Patients Who Had Previous Bypass Operation (CABG) Undergoing Invasive Coronary Angiography September 19, 2022 Disclosure: TBA
Dr. Jung-Min Ahn and Dr. C. Michael Gibson Discuss: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial September 19, 2022 Disclosure: TBA
Dr. Dominick Angiolillo and Dr. C. Michael Gibson Discuss: Aspirin Monotherapy versus Thiopyridine Therapy – Do We Have All The Answers Given There is a New Generation of Aspirin September 19, 2022 Disclosures: TBD
Dr. Walid Saliba and Dr. C. Michael Gibson Discuss: The Next Generation of WATCHMAN FLX – Video #2 September 19, 2022 Disclosures: TBD
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: TCT 2022 Daily Wrap-Up – September 18 2022 View Video September 18, 2022 Disclosures: TBA
Dr. Jonas Lanz and Dr. Yazan Daaboul Discuss: Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis September 18, 2022 Disclosure: TBA
Dr. Renuka Jain and Dr. C. Michael Gibson Discuss: Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement: Updates from the Intrepid Pilot Study September 18, 2022 Disclosure: TBA
Dr. Philippe Genereux Presents: Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results from the PARTNER Trials September 18, 2022 Disclosure: TBA
Dr. Santiago Garcia and Dr. C. Michael Gibson Discuss: Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data September 18, 2022 Disclosure: TBA
Dr. Deepak L. Bhatt and Dr. C. Michael Gibson Discuss: Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-year Follow-up of the SYMPLICITY HTN-3 Trial September 18, 2022 Disclosure: TBA
